CVR number 18662671
Industry 46.4620 Wholesale of pharmaceutical goods

HELLE HENRIKSEN MEDICINSKE UDSTYR ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Bankruptcy risk for industry  1.1% 1.1% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 1.2% 1.7% 4.2%  
Credit score (0-100)  0 0 83 75 50  
Credit rating  N/A N/A A A BBB  
Credit limit (kDKK)  0.0 0.0 67.6 2.7 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 1,874 1,173 73.5  
EBITDA  0.0 0.0 1,281 767 -26.1  
EBIT  0.0 0.0 1,176 656 -88.0  
Pre-tax profit (PTP)  0.0 0.0 1,152.0 645.0 -93.9  
Net earnings  0.0 0.0 881.0 502.0 -73.3  
Pre-tax profit without non-rec. items  0.0 0.0 1,152 645 -93.9  
 
See the entire income statement

Balance sheet (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Tangible assets total  0.0 0.0 565 471 532  
Shareholders equity total  0.0 0.0 1,626 1,327 754  
Interest-bearing liabilities  0.0 0.0 754 178 142  
Balance sheet total (assets)  0.0 0.0 3,422 1,818 949  
Net Debt  0.0 0.0 -1,293 -1,037 -230  
 
See the entire balance sheet

Volume 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 1,874 1,173 73.5  
Gross profit growth  0.0% 0.0% 0.0% -37.4% -93.7%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 3,422 1,818 949  
Balance sheet change%  0.0% 0.0% 0.0% -46.9% -47.8%  
Added value  0.0 0.0 1,281.0 761.0 -26.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 460 -205 -1  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 2.0 -1.0  

Profitability 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 62.8% 55.9% -119.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 34.4% 25.0% -6.4%  
ROI %  0.0% 0.0% 48.8% 33.3% -7.2%  
ROE %  0.0% 0.0% 54.2% 34.0% -7.0%  

Solidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Equity ratio %  0.0% 0.0% 47.5% 73.0% 79.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -100.9% -135.2% 880.5%  
Gearing %  0.0% 0.0% 46.4% 13.4% 18.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 6.6% 2.4% 3.6%  

Liquidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Quick Ratio  0.0 0.0 1.3 2.9 2.2  
Current Ratio  0.0 0.0 1.6 2.9 2.2  
Cash and cash equivalent  0.0 0.0 2,047.0 1,215.0 371.8  

Capital use efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 1,091.0 886.0 231.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0